Precursor-Directed Diversification of Cyclic Tetrapeptidic Pseudoxylallemycins

Chembiochem. 2018 Nov 2;19(21):2307-2311. doi: 10.1002/cbic.201800503. Epub 2018 Oct 4.

Abstract

Cyclic peptides containing non-proteinogenic amino acids often exhibit a broad bioactivity spectrum and many have entered clinical trials with good prospects for drug development. We recently reported the discovery of six cyclic tetrapeptides, pseudoxylallemycins A-F (1-6), from a termite-associated Pseudoxylaria sp. X802. These compounds contain a rare O-homoallenyl-l-tyrosine moiety and show promising antimicrobial activity against the Gram-negative pathogenic bacterium Pseudomonas aeruginosa. To perform more detailed structure-activity studies, we pursued a precursor-directed diversification strategy. Herein, we report the purification, identification, and testing of 21 new pseudoxylallemycin derivatives.

Keywords: allenes; amino acids; bioactivity; natural products; peptides; synthases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology*
  • Ascomycota / chemistry*
  • Isoptera / microbiology
  • Microbial Sensitivity Tests
  • Peptides, Cyclic / chemistry*
  • Peptides, Cyclic / pharmacology*
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Structure-Activity Relationship

Substances

  • Anti-Bacterial Agents
  • Peptides, Cyclic